EDGAR Filing Documents for 0001047469-02-006968

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0001047469-02-006968

Filing Date

2002-12-13

Accepted

2002-12-13 17:28:54

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS,L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	a2096253zsc13d.htm	SC 13D	94042
3	EXHIBIT 1	a2096253zex-1.htm	EX-1	10317
4	EXHIBIT 2	a2096253zex-2.htm	EX-2	421778
5	EXHIBIT 3	a2096253zex-3.htm	EX-3	70645
6	EXHIBIT 4	a2096253zex-4.htm	EX-4	70869
	Complete submission text file	0001047469-02-006968.txt		670286

Mailing Address 3650 WESBROOK MALL VANCOUVER BC V6SL2 A1 00000

Business Address 1750 609 GRANVILLE ST VANCOUVER B C CANADA A1 00000

MICROLOGIX BIOTECH INC (Subject) CIK: 0000915458 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0430
Type: SC 13D | Act: 34 | File No.: 005-78624 | Film No.: 02857686
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606

Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice